BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34518524)

  • 1. LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma.
    Tao M; Luo J; Gu T; Yu X; Song Z; Jun Y; Gu H; Han K; Huang X; Yu W; Sun S; Zhang Z; Liu L; Chen X; Zhang L; Luo C; Wang Q
    Cell Death Dis; 2021 Sep; 12(9):845. PubMed ID: 34518524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased lysophosphatidylcholine acyltransferase 1 expression is unrelated to prognosis of esophageal cancer patients.
    Bellon E; Grupp K; Ghadban T; Tachezy M; Bachmann K; Izbicki JR; Simon R; Sauter G; Hube-Magg C; Melling N
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2879-2884. PubMed ID: 34148155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-106b-5p regulates esophageal squamous cell carcinoma progression by binding to HPGD.
    Yang F; Sun Z; Wang D; Du T
    BMC Cancer; 2022 Mar; 22(1):308. PubMed ID: 35317779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Cell-Derived Complement Component C1r Acts as a Prognostic Biomarker and Promotes Esophageal Squamous Cell Carcinoma Progression.
    Tang M; Zhao S; Ren L; Li Q; Li L; Wang C; Meng C; Chen Y; Hu W
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):138. PubMed ID: 38682192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAP/TEAD4-induced KIF4A contributes to the progression and worse prognosis of esophageal squamous cell carcinoma.
    Li Y; Zhu X; Yang M; Wang Y; Li J; Fang J; Guo W; Ma S; Guan F
    Mol Carcinog; 2021 Jul; 60(7):440-454. PubMed ID: 34003522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RASSF6-TRIM16 axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.
    Zheng L; Zhao Z; Rong L; Xue L; Song Y
    J Genet Genomics; 2019 Oct; 46(10):477-488. PubMed ID: 31812473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAF2 overexpression predicts poor prognosis and promotes tumorigenesis in esophageal squamous cell carcinoma.
    Qian Z; Wei B; Zhou Y; Wang Q; Wang J; Sun Y; Gao Y; Chen X
    BMC Cancer; 2019 Jun; 19(1):585. PubMed ID: 31200670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NUPR1 induces autophagy and promotes the progression of Esophageal squamous cell carcinoma via the MAPK-mTOR pathway.
    Ren S; Chen Y; Wang Q; Song L; Xin Z; Shi M; Liu X
    Pathol Res Pract; 2024 May; 257():155323. PubMed ID: 38653091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HERG1 promotes esophageal squamous cell carcinoma growth and metastasis through TXNDC5 by activating the PI3K/AKT pathway.
    Wang H; Yang X; Guo Y; Shui L; Li S; Bai Y; Liu Y; Zeng M; Xia J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):324. PubMed ID: 31331361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
    Sun Q; Fu C; Liu J; Li S; Zheng J
    Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
    Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
    Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
    Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
    Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma.
    Ma J; Xiao Y; Tian B; Chen S; Zhang B; Wu J; Wu Z; Li X; Tang J; Yang D; Zhou Y; Wang H; Su M; Wang W
    J Cell Biochem; 2020 Feb; 121(2):1374-1387. PubMed ID: 31512786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non‑coding RNA MEG3 suppresses epithelial‑to‑mesenchymal transition by inhibiting the PSAT1‑dependent GSK‑3β/Snail signaling pathway in esophageal squamous cell carcinoma.
    Li MK; Liu LX; Zhang WY; Zhan HL; Chen RP; Feng JL; Wu LF
    Oncol Rep; 2020 Nov; 44(5):2130-2142. PubMed ID: 32901893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR-1224-5p/TNS4/EGFR axis inhibits tumour progression in oesophageal squamous cell carcinoma.
    Shi ZZ; Wang WJ; Chen YX; Fan ZW; Xie XF; Yang LY; Chang C; Cai Y; Hao JJ; Wang MR; Bai J
    Cell Death Dis; 2020 Jul; 11(7):597. PubMed ID: 32732965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA ATB promotes malignancy of esophageal squamous cell carcinoma by regulating miR-200b/Kindlin-2 axis.
    Li Z; Wu X; Gu L; Shen Q; Luo W; Deng C; Zhou Q; Chen X; Li Y; Lim Z; Wang X; Wang J; Yang X
    Cell Death Dis; 2017 Jun; 8(6):e2888. PubMed ID: 28640252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA hsa_circ_0000654 promotes esophageal squamous cell carcinoma progression by regulating the miR-149-5p/IL-6/STAT3 pathway.
    Xu Z; Tie X; Li N; Yi Z; Shen F; Zhang Y
    IUBMB Life; 2020 Mar; 72(3):426-439. PubMed ID: 31778020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.